This review discusses the interdependence of hypertriglyceridemia, diabetes, and coronary vessel disease, along with their differentiation and therapeutic approaches.
Review synthesizes hypertriglyceridemia-diabetes-CAD links and therapies; leaves open optimal integrated strategies for prospective validation.
Hypertriglyceridemia, diabetes, and coronary vessel disease are often interdependent disorders. Hyperglyceridemia may be exogenous, endogenous, or mixed. It may be familial or secondary to a host of different disorders. The clinical and chemical differentiation of hyperglyceridemia is discussed as are the roles of glucose intolerance, insulin response, dietary carbohydrate and fat, and obesity in each type of hyperglyceridemia. Specific therapeutic approaches which are designed to ameliorate at least the chemical manifestations of these disorders are reviewed.
No takes yet. Share an insight, caveat, or question.
Robert I. Levy (1969) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: